Metformin and Nightly Fasting in Women With Early Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Anatomic Stage I Breast Cancer AJCC v8|Anatomic Stage II Breast Cancer AJCC v8|Breast Ductal Carcinoma In Situ|Invasive Breast Carcinoma
Interventions: PROCEDURE: Biospecimen Collection|DRUG: Extended Release Metformin Hydrochloride|OTHER: Monitoring|OTHER: Nutritional Assessment|OTHER: Short-Term Fasting
Sponsor: M.D. Anderson Cancer Center
Collaborators: National Cancer Institute (NCI)